Onychomycosis (Tinea Unguium) Drug Market Report

China Onychomycosis (Tinea Unguium) Drug Industry Market Research Report 2023-2029

  • POSTDATE：Sep 26, 2023
  • PAGES：170
  • REPORT CODE：GMM1814548
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Psoriasis refers to the disease caused by the encroachment of dermatophytosis on deck or under armour.Onychomycosis is a type of nail infection caused by dermatophytes, yeasts, and non-dermatophytes.

    This report elaborates on the current development of the Onychomycosis (Tinea Unguium) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Valeant Pharma

    • Torrent Pharma

    • Moberg

    • Zhejiang Deyer

    • Yangtze River

    • Pfizer

    • Qilu Pharmaceutical

    • Galderma

    • J&J

    • TARO

    • Novartis

    • Perrigo

    • Chengdu Brilliant

    By Type:

    • Oral medication

    • External medicine

    By Application:

    • The Middle-aged

    • The Aged

    • Children

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Onychomycosis (Tinea Unguium) Drug Market Overview 2018-2029

    • 1.1 China Onychomycosis (Tinea Unguium) Drug Industry Development Overview

    • 1.2 China Onychomycosis (Tinea Unguium) Drug Industry Development History

    • 1.3 China Onychomycosis (Tinea Unguium) Drug Industry Market Size (2018-2029)

    • 1.4 China Onychomycosis (Tinea Unguium) Drug Market Analysis by Type from Production Side

      • 1.4.1 China Onychomycosis (Tinea Unguium) Drug Production Volume, Production Value and Growth Rate of Oral medication (2018-2029)

      • 1.4.2 China Onychomycosis (Tinea Unguium) Drug Production Volume, Production Value and Growth Rate of External medicine (2018-2029)

    • 1.5 China Onychomycosis (Tinea Unguium) Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Onychomycosis (Tinea Unguium) Drug Sales Volume, Sales Value and Growth Rate of The Middle-aged (2018-2029)

      • 1.5.2 China Onychomycosis (Tinea Unguium) Drug Sales Volume, Sales Value and Growth Rate of The Aged (2018-2029)

      • 1.5.3 China Onychomycosis (Tinea Unguium) Drug Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

    • 1.6 China Onychomycosis (Tinea Unguium) Drug Market Analysis by Region

      • 1.6.1 North China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Onychomycosis (Tinea Unguium) Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Onychomycosis (Tinea Unguium) Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Onychomycosis (Tinea Unguium) Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Onychomycosis (Tinea Unguium) Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Onychomycosis (Tinea Unguium) Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Onychomycosis (Tinea Unguium) Drug Industry Development

    Chapter 3 Onychomycosis (Tinea Unguium) DrugIndustry Chain Analysis

    • 3.1 Onychomycosis (Tinea Unguium) Drug Industry Chain

    • 3.2 Onychomycosis (Tinea Unguium) Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Onychomycosis (Tinea Unguium) Drug Market

    • 3.3 Onychomycosis (Tinea Unguium) Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Onychomycosis (Tinea Unguium) Drug Market

    Chapter 4 China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 4.1 China Onychomycosis (Tinea Unguium) Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Onychomycosis (Tinea Unguium) Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Onychomycosis (Tinea Unguium) Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Onychomycosis (Tinea Unguium) Drug Production Volume and Growth Rate of Oral medication

      • 4.5.2 China Onychomycosis (Tinea Unguium) Drug Production Volume and Growth Rate of External medicine

    Chapter 5 China Onychomycosis (Tinea Unguium) Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Onychomycosis (Tinea Unguium) Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate of The Middle-aged

      • 5.5.2 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate of The Aged

      • 5.5.3 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate of Children

    Chapter 6 China Onychomycosis (Tinea Unguium) Drug Market, by Region

    • 6.1 China Onychomycosis (Tinea Unguium) Drug Production Volume and Production Value, by Region

    • 6.2 China Onychomycosis (Tinea Unguium) Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Onychomycosis (Tinea Unguium) Drug Market Analysis

    • 7.1 North China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 7.2 North China Onychomycosis (Tinea Unguium) Drug Market, by Application

    Chapter 8 Central China Onychomycosis (Tinea Unguium) Drug Market Analysis

    • 8.1 Central China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 8.2 Central China Onychomycosis (Tinea Unguium) Drug Market, by Application

    Chapter 9 South China Onychomycosis (Tinea Unguium) Drug Market Analysis

    • 9.1 South China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 9.2 South China Onychomycosis (Tinea Unguium) Drug Market, by Application

    Chapter 10 East China Onychomycosis (Tinea Unguium) Drug Market Analysis

    • 10.1 East China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 10.2 East China Onychomycosis (Tinea Unguium) Drug Market, by Application

    Chapter 11 Northeast China Onychomycosis (Tinea Unguium) Drug Market Analysis

    • 11.1 Northeast China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 11.2 Northeast China Onychomycosis (Tinea Unguium) Drug Market, by Application

    Chapter 12 Southwest China Onychomycosis (Tinea Unguium) Drug Market Analysis

    • 12.1 Southwest China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 12.2 Southwest China Onychomycosis (Tinea Unguium) Drug Market, by Application

    Chapter 13 Northwest China Onychomycosis (Tinea Unguium) Drug Market Analysis

    • 13.1 Northwest China Onychomycosis (Tinea Unguium) Drug Market, by Type

    • 13.2 Northwest China Onychomycosis (Tinea Unguium) Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Valeant Pharma

        • 14.1.1 Valeant Pharma Company Profile

        • 14.1.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Torrent Pharma

        • 14.2.1 Torrent Pharma Company Profile

        • 14.2.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Moberg

        • 14.3.1 Moberg Company Profile

        • 14.3.2 Moberg Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Zhejiang Deyer

        • 14.4.1 Zhejiang Deyer Company Profile

        • 14.4.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Yangtze River

        • 14.5.1 Yangtze River Company Profile

        • 14.5.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Pfizer

        • 14.6.1 Pfizer Company Profile

        • 14.6.2 Pfizer Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Qilu Pharmaceutical

        • 14.7.1 Qilu Pharmaceutical Company Profile

        • 14.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Galderma

        • 14.8.1 Galderma Company Profile

        • 14.8.2 Galderma Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 J&J

        • 14.9.1 J&J Company Profile

        • 14.9.2 J&J Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 TARO

        • 14.10.1 TARO Company Profile

        • 14.10.2 TARO Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Novartis

        • 14.11.1 Novartis Company Profile

        • 14.11.2 Novartis Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Perrigo

        • 14.12.1 Perrigo Company Profile

        • 14.12.2 Perrigo Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Chengdu Brilliant

        • 14.13.1 Chengdu Brilliant Company Profile

        • 14.13.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Onychomycosis (Tinea Unguium) Drug Industry Research Conclusions

    • 15.2 Onychomycosis (Tinea Unguium) Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Onychomycosis (Tinea Unguium) Drug Industry Market Size (2018-2029)

    • Figure China Onychomycosis (Tinea Unguium) Drug Production Volume, Production Value and Growth Rate of Oral medication (2018-2029)

    • Figure China Onychomycosis (Tinea Unguium) Drug Production Volume, Production Value and Growth Rate of External medicine (2018-2029)

    • Figure China Onychomycosis (Tinea Unguium) Drug Sales Volume, Sales Value and Growth Rate of The Middle-aged (2018-2029)

    • Figure China Onychomycosis (Tinea Unguium) Drug Sales Volume, Sales Value and Growth Rate of The Aged (2018-2029)

    • Figure China Onychomycosis (Tinea Unguium) Drug Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

    • Figure North China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate from 2018-2029

    • Figure Onychomycosis (Tinea Unguium) Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Onychomycosis (Tinea Unguium) Drug Market Share by Type in 2018

    • Figure China Onychomycosis (Tinea Unguium) Drug Market Share by Type in 2023

    • Figure China Onychomycosis (Tinea Unguium) Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Production Volume and Growth Rate of Oral medication (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Production Volume and Growth Rate of External medicine (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2018

    • Figure China Onychomycosis (Tinea Unguium) Drug Market Share by Application in 2023

    • Figure China Onychomycosis (Tinea Unguium) Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate of The Middle-aged (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate of The Aged (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate of Children (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Production Volume by Region (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Region (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Region (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Production Value by Region (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Production Value Share by Region (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Production Value Share by Region (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Sales Volume by Region (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Region (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Region (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Sales Value by Region (2018-2023)

    • Table China Onychomycosis (Tinea Unguium) Drug Sales Value Share by Region (2018-2023)

    • Figure China Onychomycosis (Tinea Unguium) Drug Sales Value Share by Region (2018-2023)

    • Table North China Onychomycosis (Tinea Unguium) Drug Production Volume by Type (2018-2023)

    • Table North China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Figure North China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Table North China Onychomycosis (Tinea Unguium) Drug Sales Volume by Application (2018-2023)

    • Table North China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Onychomycosis (Tinea Unguium) Drug Production Volume by Type (2018-2023)

    • Table Central China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Table Central China Onychomycosis (Tinea Unguium) Drug Sales Volume by Application (2018-2023)

    • Table Central China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Table South China Onychomycosis (Tinea Unguium) Drug Production Volume by Type (2018-2023)

    • Table South China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Figure South China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Table South China Onychomycosis (Tinea Unguium) Drug Sales Volume by Application (2018-2023)

    • Table South China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Table East China Onychomycosis (Tinea Unguium) Drug Production Volume by Type (2018-2023)

    • Table East China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Figure East China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Table East China Onychomycosis (Tinea Unguium) Drug Sales Volume by Application (2018-2023)

    • Table East China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Onychomycosis (Tinea Unguium) Drug Production Volume by Type (2018-2023)

    • Table Northeast China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Onychomycosis (Tinea Unguium) Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Onychomycosis (Tinea Unguium) Drug Production Volume by Type (2018-2023)

    • Table Southwest China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Onychomycosis (Tinea Unguium) Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Onychomycosis (Tinea Unguium) Drug Production Volume by Type (2018-2023)

    • Table Northwest China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Onychomycosis (Tinea Unguium) Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Onychomycosis (Tinea Unguium) Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Onychomycosis (Tinea Unguium) Drug Sales Volume Share by Application (2018-2023)

    • Table Valeant Pharma Company Profile

    • Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Torrent Pharma Company Profile

    • Table Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Moberg Company Profile

    • Table Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Zhejiang Deyer Company Profile

    • Table Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Yangtze River Company Profile

    • Table Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Qilu Pharmaceutical Company Profile

    • Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Galderma Company Profile

    • Table Galderma Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table J&J Company Profile

    • Table J&J Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table TARO Company Profile

    • Table TARO Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Perrigo Company Profile

    • Table Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)

    • Table Chengdu Brilliant Company Profile

    • Table Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US